(secondQuint)A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.

.

 This was a prospective, randomized, double-blind, placebo-controlled, study.

 Subjects were randomized to receive either CAIV-T or Placebo.

 All subjects were healthy children and adolescents aged at least 6 years of age and less than 18 years of age at the time of enrollment.

.

 A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.

@highlight

A safety study to compare, over a 7 day period, the fever rates following one dose of either Influenza Virus Vaccine or placebo administered outside the influenza season to healthy children and adolescents aged 6 to less than 18 years.

